Leigh A Johnson1,2, Adriana Gamboa1, Raul Vintimilla1, Austin J Cheatwood3, Alyann Grant4, Ashesh Trivedi5, Melissa Edwards1, James R Hall2,6, Sid E O'Bryant1,2. 1. Department of Internal Medicine, University of North Texas Health Science Center, Fort Worth, TX, USA. 2. Institute for Aging & Alzheimer's Disease Research, University of North Texas Health Science Center, Fort Worth, TX, USA. 3. Loyola University, New Orleans, LA, USA. 4. Washington College, Chestertown, MD, USA. 5. Yale University, New Haven, CT, USA. 6. Department of Psychiatry, University of North Texas Health Science Center, Fort Worth, TX, USA.
Abstract
BACKGROUND: The links between diabetes, depression, and Alzheimer's disease (AD) has been established, but they are still poorly understood. However, little research has examined the effect that comorbidity of depression and diabetes has on cognitive impairment in an ethnically diverse sample. OBJECTIVE: The purpose of this study was to investigate the relationship between comorbid diabetes and depression on cognitive dysfunction; and examine the relationship in an ethnically diverse population. METHODS AND RESULTS: Analyses of data from 2,436 participants (914 men and 1,522 women) of three separate cohorts: HABLE, FRONTIER, and TARCC. In the HABLE cohort, comorbidity (odds ratio [OR] = 3.008; 95% CI = 1.358-6.667), age (OR = 1.138; 95% CI = 1.093-1.185), and education (OR = 0.915; 95% CI = 0.852-0.982) increased the risk of mild cognitive impairment (MCI) diagnosis among elderly Mexican American. In the TARCC cohort, results showed an increase risk of MCI in both non-Hispanic whites (OR = 18.795; 95% CI = 2.229-158.485) and Mexican Americans (OR = 8.417; 95% CI = 2.967-23.878). Finally, results in the FRONTIER cohort showed that in elderly Mexican Americans, comorbidity (OR = 2.754; 95% CI = 1.084-6.995) and age (OR = 1.069; 95% CI = 1.023-1.118) significantly increased risk of MCI. In non-Hispanic whites, comorbidity did not significantly increase risk of MCI. CONCLUSIONS: Among elderly Mexican Americans, comorbid depression and diabetes significantly increased risk for MCI and AD across cohorts. Effects of comorbid diabetes and depression on MCI were inconclusive. Our results support the link between comorbid diabetes and depression and risk for cognitive decline among Mexican Americans. This finding is of critical importance as the Hispanic population is at higher risk of developing AD.
BACKGROUND: The links between diabetes, depression, and Alzheimer's disease (AD) has been established, but they are still poorly understood. However, little research has examined the effect that comorbidity of depression and diabetes has on cognitive impairment in an ethnically diverse sample. OBJECTIVE: The purpose of this study was to investigate the relationship between comorbid diabetes and depression on cognitive dysfunction; and examine the relationship in an ethnically diverse population. METHODS AND RESULTS: Analyses of data from 2,436 participants (914 men and 1,522 women) of three separate cohorts: HABLE, FRONTIER, and TARCC. In the HABLE cohort, comorbidity (odds ratio [OR] = 3.008; 95% CI = 1.358-6.667), age (OR = 1.138; 95% CI = 1.093-1.185), and education (OR = 0.915; 95% CI = 0.852-0.982) increased the risk of mild cognitive impairment (MCI) diagnosis among elderly Mexican American. In the TARCC cohort, results showed an increase risk of MCI in both non-Hispanic whites (OR = 18.795; 95% CI = 2.229-158.485) and Mexican Americans (OR = 8.417; 95% CI = 2.967-23.878). Finally, results in the FRONTIER cohort showed that in elderly Mexican Americans, comorbidity (OR = 2.754; 95% CI = 1.084-6.995) and age (OR = 1.069; 95% CI = 1.023-1.118) significantly increased risk of MCI. In non-Hispanic whites, comorbidity did not significantly increase risk of MCI. CONCLUSIONS: Among elderly Mexican Americans, comorbid depression and diabetes significantly increased risk for MCI and AD across cohorts. Effects of comorbid diabetes and depression on MCI were inconclusive. Our results support the link between comorbid diabetes and depression and risk for cognitive decline among Mexican Americans. This finding is of critical importance as the Hispanic population is at higher risk of developing AD.
Authors: James R Hall; Valerie Hobson Balldin; Adriana Gamboa; Melissa L Edwards; Leigh A Johnson; Sid E O'Bryant Journal: Dev Neuropsychol Date: 2017-11-29 Impact factor: 2.253
Authors: Samantha E John; Ashita S Gurnani; Cara Bussell; Jessica L Saurman; Jason W Griffin; Brandon E Gavett Journal: Neuropsychology Date: 2016-11 Impact factor: 3.295
Authors: Maria E Garcia; Lisa Ochoa-Frongia; Nathalie Moise; Adrian Aguilera; Alicia Fernandez Journal: J Gen Intern Med Date: 2017-12-18 Impact factor: 5.128
Authors: Jaime Perales-Puchalt; Michelle L Vidoni; Juan Llibre Rodríguez; Eric D Vidoni; Sandra Billinger; Jeffrey Burns; Maëlenn Guerchet; MinJae Lee Journal: Int J Geriatr Psychiatry Date: 2019-04-23 Impact factor: 3.485
Authors: Jessica L McCurley; Angela P Gutierrez; Julia I Bravin; Neil Schneiderman; Samantha A Reina; Tasneem Khambaty; Sheila F Castañeda; Sylvia Smoller; Martha L Daviglus; Matthew J O'Brien; Mercedes R Carnethon; Carmen R Isasi; Krista M Perreira; Greg A Talavera; Mingan Yang; Linda C Gallo Journal: Ann Behav Med Date: 2019-10-07